Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

A neck lesion misdiagnosed as benign was later treated successfully with Mohs Micrographic Surgery.

Recognizing the link between certain autoimmune disorders and neurological conditions can improve diagnosis and treatment.

The cyst had unusual keratin spherules and resembled bone marrow.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Folliculotropic mycosis fungoides can look like alopecia areata.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Both azathioprine and betamethasone treatments effectively regrow hair in alopecia areata, but azathioprine may be safer.

A rare hair follicle tumor in the hand was successfully removed with no return after four years.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Bortezomib chemotherapy can cause temporary skin rashes.

Reticular erythematous mucinosis syndrome can occur with minimal mucin deposition.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

JAK inhibitors may help improve symptoms in adults with APECED.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Reflectance confocal microscopy can noninvasively diagnose onychomatricoma by showing unique features different from healthy nails or nail fungus.

Milia en plaque can be caused by skin damage, tumors, or external factors.